INBX: Inhibrx Biosciences, Inc. Stock

by  •  • Comments Off on INBX: Inhibrx Biosciences, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 166.04
Enterprise Value ($M) 13.44
Book Value ($M) 133.58
Book Value / Share 9.23
Price / Book 1.24
NCAV ($M) 113.22
NCAV / Share 7.82
Price / NCAV 1.47

Profitability (mra)
Return on Invested Capital (ROIC) 11.92
Return on Assets (ROA) 59.80
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 3.89
Current Ratio 3.94

Balance Sheet (mrq) ($M)
Current Assets 160.40
Assets 180.77
Liabilities 47.18
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.20
Operating Income -331.45
Net Income 1,687.57

Cash Flow Statement (mra) ($M)
Cash From Operations -194.41
Cash from Investing -2.60
Cash from Financing 71.68

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-26 13D/A Lappe Mark 6.40 21.54
02-26 13D/A The Jon F. Kayyem and Paige Gates-Kayyem Family Trust 7.90
02-04 13G BlackRock, Inc. 5.70
11-14 13G Perceptive Advisors Llc 9.90 -24.39
06-07 13G Viking Global Investors Lp 12.30
06-03 13D Kayyem Jon Faiz 5.65
05-31 13G Sanofi 8.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 12,254 71,117 17.23
2025-04-16 12,419 51,466 24.13
2025-04-15 14,084 57,355 24.56
2025-04-14 16,971 91,854 18.48

(click for more detail)

Similar Companies
IGMS – IGM Biosciences, Inc. IMUX – Immunic, Inc.
IMVT – Immunovant, Inc. INDV – Indivior PLC
INNV – InnovAge Holding Corp.


Financial data and stock pages provided by
Fintel.io